Learn more

SIRS LAB GMBH

Overview
  • Total Patents
    89
About

SIRS LAB GMBH has a total of 89 patent applications. Its first patent ever was published in 2001. It filed its patents most often in Germany, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and micro-structure and nano-technology are BEIJING ACCB BIOTECH LTD, CHROMACODE INC and GUANGDONG ASCENDAS GENOMICS TECH CO LTD.

Patent filings per year

Chart showing SIRS LAB GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Russwurm Stefan 53
#2 Reinhart Konrad 30
#3 Deigner Hans-Peter 23
#4 Ruswurm Stefan 16
#5 Straube Eberhard 12
#6 Saluz Hans-Peter 9
#7 Lehmann Marc 7
#8 Zipfel Peter Franz 6
#9 Schmidt Karl-Hermann 6
#10 Landre Julien 5

Latest patents

Publication Filing date Title
US2011076685A1 Method for in vitro detection and differentiation of pathophysiological conditions
EP2309001A1 Method for in vitro recording and differentiation of pathophysiological states
DE102009044085A1 Method for in vitro detection and differentiation of pathophysiological conditions
DE102008000715A1 Method for in vitro detection and differentiation of pathophysiological conditions
DE102007041864A1 Method for the detection of bacteria and fungi
DE102007036678A1 Use of polynucleotides to detect gene activities to distinguish between local and systemic infection
DE102007010252A1 Control genes for the normalization of gene expression analysis data
DE102006019480A1 Method for in-vitro monitoring of postoperative changes after liver transplantation
WO2006133758A2 Device for enriching/separating dna containing unmethylated cpg motives
DE102006003814A1 Diagnosis of Chlamydophila pneumoniae infection comprises assaying a sample for heat shock protein J or for antibodies directed against this protein
DE102005057753A1 In vitro diagnosis, risk assessment and/or progress control of sepsis or generalized acute inflammation, by measuring level of immunoglobulin A and/or its derivative in patient sample
DE102005056839A1 Assay for diagnosis of sepsis or generalized acute inflammation comprises determining the transthyretin content of a sample from a patient and comparing it with a control group
DE102005056793A1 Assay for diagnosis of sepsis or generalized acute inflammation comprises determining the beta-actin and/or gamma-actin content of a sample from a patient and comparing it with a control group
DE102005056838A1 Sepsis diagnosis is made more specific by in vitro measurement of extra-cellular hemoglobin concentration and comparision of results with those from a control group
DE102005042132A1 Method for diagnosis, assessment and monitoring of sepsis or generalized inflammation, comprises measuring content of immunoglobulin M in a patient sample
DE102005042133A1 Method for the diagnosis of sepsis with apolipoprotein A1
DE102005042100A1 Method for diagnosis, assessment and monitoring of sepsis or generalized inflammation, comprises measuring content of haptoglobin-related protein in a patient sample
DE102005013013A1 Use of gene activity classifiers for the in vitro classification of gene expression profiles of patients with infectious / non-infectious multi-organ failure
CA2558515A1 Method of enriching and/or separating prokaryotic dna by means of a protein which specifically binds dna containing non-methylated cpg motifs
DE102005001889A1 A method of increasing the binding capacity and efficiency of a protein that specifically binds DNA containing non-methylated CPG motifs